Clinical Data Explorer
February 26, 2025
February 26, 2025
With this release, we're introducing a powerful new workflow that significantly streamlines the process of researching and benchmarking clinical trial data. The Clinical Data Explorer leverages our AI to rapidly pull together key endpoints, patient populations, and results for multiple assets, allowing you to build clinical data tables in minutes instead of weeks.
Why does this matter for you? By understanding existing approved and candidate therapies—particularly the performance of assets on critical endpoints—you can better assess how a new therapy might stack up against current standards. We developed this workflow in direct response to customers who repeatedly told us how time-consuming it is to gather this data by hand.
Now, we’re offering an agentic experience that follows a curated work plan—designed by domain experts—so you can complete this research collaboratively and efficiently while maintaining full transparency into every step.
Choose the Clinical Data Explorer from the Workflows start card.
Describe the indication and phase you're researching. In this example, we're investigating Phase 2 drugs for Glioblastoma.
The AI will automatically generate a search description, key info description, and search type, ensuring your query is aligned with what you need.
In this case, our search returns 75 drugs. We'll limit to the first 10 for demonstration.
To refine your research, the AI will suggest key endpoints relevant to the space you’re exploring.
Autopilot Mode lets the AI complete the research and synthesis, generating your final report with minimal effort.
Once finished, you can view the report, including an executive summary and the custom table with columns you defined.
With the Clinical Data Explorer, you can now quickly assess how new and existing therapies stack up against competitors, ultimately helping you make better-informed decisions and accelerate your market intelligence process.
Watchlists
February 12, 2025
February 12, 2025
A common challenge our users face is staying informed about fast-moving developments in the life sciences industry—whether it’s tracking specific companies, clinical trials, or newly announced therapies.
To address this, we’re excited to introduce Watchlists: a streamlined way to aggregate and monitor the organizations, products, and trials that matter most to you.
1. Create a New Watchlist
From the start page, click the button to create a new watchlist.
2. Add Items to Your Watchlist
Populate your watchlist with companies, drugs, or trials. You can add individual items one at a time...
...or you can import an existing list in bulk:
3. Monitor Your Event Feed
Once your watchlist is set up, head back to the event feed to view timely updates on the items you’re tracking.
As always, events are filterable by date, type, company, and more, letting you quickly spot the news that matters to you:
With Watchlists, you can follow the exact events you need—minus the noise of endless press releases or sprawling clinical trial databases. We’re continually refining our event monitoring, speeding up data ingestion, improving relevance, and rolling out notifications. Stay tuned for more enhancements!
Mobile Layouting Improvments
January 29, 2025
January 29, 2025
Though we're primarily a desktop-focused app, we heard from users that it can be useful to use Maven Bio on the go - particularly our Assistant / AI Answers functionality.
When on a mobile device, we've made it the default tab, so you can get the answers you need as quick as possible.
Though our Assistant is now the default, it doesn't mean the rest of the application is inaccessible. By switching to the dashboard in the top right, you still have access to our other tools. With Compass, you can still do searches for drugs, trials, companies, or documents
With Atlas Landscapes, you can continue to view and request Landscape reports - including our common indications or bespoke reports to fit your exact needs.
Finally, with Atlas Profiles, you can check in on companies, drugs, and trials, and double-check the facts before your next meeting, or brainstorm some research on the go.
Moving forward, we'll try and keep the bulk of our core functionality available - whether you're on a workstation PC at the office, a tablet in a meeting, or on your phone on the train.
Report Improvements
January 15, 2025
January 15, 2025
When we launched the Maven Bio platform out of beta, we focused on our Landscape Reports as our flagship feature. Since then, we've been hard at work improving the whole platform, including our reports. In this update, we're making reports faster to access, better to export, and more information dense.
When you want to get quickly up to speed on the landscape for an indication, it can be frustrating to have to wait for the report to generate. Now, we've generated reports for many of the most common indications that are instantly available.
For example, let's look at Dementia. We can open up the reports tab, and filter for Dementia.
Alternatively, when a report isn't available, you'll have the option to request it:
Over time, we'll keep growing the number of instantly available reports, so you can get the information you need as quickly as possible.
To support your research, we make all our reports exportable. In this update, we've drastically improved our exporting to spreadsheets. Instead of a hard-to-use .csv file, we now support exporting right to a nicely formatted Excel workbook.
On any report, you can click the export button:
It will take a moment to format, then make the excel workbook available to you.
This will download a .xlsx file that has the tables from the report richly formatted. Each table has its own sheet, with properly formatted columns and rich-text in the cells.
In addition to our radar chart, we want to add more visual information to our reports. For this, we've added some secondary charts to the reports.
At a glance, you can see the breakdown of phases for tracked drugs in the pipeline for an indication.
With a bar chart, you can visualize the product types that comprise the landscape.
Or, you can see what upcoming therapies are currently in research programs.
These are just a few of the charts you'll see across our landscape reports.
With our first set of updates in the new year, we've continued to bolster our competitive landscaping capacity. Quicker access, easier exporting, and simpler visuals. We hope you'll find that our improved reports will continue to expedite your work, and that the charts will supplement our text synthesis and rich datagrids well.
AI Filters, AI Research Logs
December 31, 2024
December 31, 2024
Since revising our search filters, users have been much more successful in searching for drugs, companies, trials, and documents. With this update, we want to make it even easier.
We understand that our search filters can be overwhelming for new users. Now, our AI can help you select search filters.
Start by entering a simple description of what you're looking for
Sometimes, the AI won't generate complete filters, so you'll need to help it pick exactly the indication or mechanism that you are looking for.
Once you have complete filters, the Apply Filters button will change from yellow to green, and you can execute your search.
You'll see the results you are looking for, with easier filtering than ever before.
In addition to helping you with search filters, we have worked to make our AI more trustworthy. To this end, we have added better insight into how the AI generated the answers it responds with. For example, let's ask for an overview of current treatment options and emerging therapies for Atopic Dermatitis.
In response, now there's a clear log of the plan the AI used to answer, and the sources it chose to respond with.
Of course, each source links back to the original document or website, so you can verify the claims made by the AI.
As we push into the new year, we will continue to be hard at work building more tools to make your research as easy as possible. Happy researching!
AI Table Builder and UX Refinement
December 18, 2024
December 18, 2024
As always, we are focused on expediting your low-level research tasks. Many of our customers love the AI-driven column and table features on Maven Bio, but found the process of building bespoke tables to be cumbersome. To this end, we built a guided flow to help build bespoke tables without having to navigate multiple different views, modals, and tabs.
To start, click the Workflows card on the start page:
You can choose to upload a spreadsheet, use an existing list, or create a new list from scratch.
If you choose to create a new list, a guiding helper will appear in the bottom-right with a checklist for the steps you should take.
Once you have selected a list or uploaded a sheet for your data source, you can select which columns to use. For a sheet, all the columns included in the uploaded file will be included.
Then, you can choose to add AI Columns. Previously, you would have to open a constrained popover repeatedly if you were trying to do a deep-dive on your rows. Now, you can easily add as many columns as you need, without unnecessary clicks or effort.
Additionally - we made it even easier, allowing the ability to automatically generate properly formatted instructions based on your column description. With this, it is significantly easier to get the information you need researched.
Finally, you can review and create your table. You can double-check your data source, re-order your columns, and add a name and description for your table.
Once complete, the table will be added to Your Lists, and you will automatically be redirected to the detail page for this table. It will have the given title, your selected columns, and start researching your AI columns.
We have already heard from users that this is a lot faster - and we are happy to make our most powerful features as easy to access as ever.
In our continued pursuit to make powerful features easier to access, we have revamped our start page.
The clear grid of app capabilities should make it easier to find what you need. With this, we have also taken a pass on the overall look of the site, with updates to our font, colors, and logo. As a small team, we are still refining the visuals and design language of the site. With these changes, we have improved visual consistency, the general user experience, and particularly tried to reduce fatigue on text-heavy views.
Revamped Filtering
December 4, 2024
December 4, 2024
Our database has millions of documents, hundreds of thousands of trials, tens of thousands of drugs, and thousands of companies updating almost every day. With such a big corpus of content, it can be hard to find exactly what you're looking for - and we hear that.
To this end, we've revamped our filtering system. Filters are now much easier to manage and apply. To get started, click the @muifilter_list/@mui Filters button on any datagrid, or the filter icon on any column definition.
This will open the new filters overlay:
This expanded interface makes it easier to manage your filters. For example, let's do a search for Phase 2-3 drugs for HER2 Negative Breast Cancer. First, we select the Indications column:
From there, search for the desired indication:
With that filter applied, let's set the relevant filter for Detailed Global Status:
Now we can see the filters we're going to apply. When we click the @muifilter_list/@mui Apply Filters button, our filters get applied, and we see the results:
It's that simple. At any time, you can update your search by re-opening the filters overlay, and adding or removing as many filters as you like. These new filters are supported across all filterable tables, so you'll see them across searches, profiles, reports, and lists, leading to a more consistent easy-to-master filtering experience throughout the application.
Even our basic filters are now easier to use, too. Across countries, disciplines, and teams, there's a wide variety of names for the indications and mechanisms that categorize drug programs and their developers. We have observed that users often struggle finding what they're looking for - and we wanted to make it as easy as possible. For this, we've greatly expanded the variants of names that we track. Looking to search for drugs to treat NASH? No need to type in the full name anymore:
Or, looking to learn about Fibroblast Growth Factor 21? Let's save us all some time and use FGF-21 as the name for it:
With these changes, it should be quicker, easier, and simpler to get to the information you need. We're all about expediting your research - and we've made another stride in doing so with this update.
AI Columns, Event Feeds, UX Improvements
November 18, 2024
November 18, 2024
We've been hard at work since coming out of beta earlier this month. With this update, we are excited to announce two major features to help you answer specific questions and understand the history of drugs, companies, and trials.
When researching a list of different drug programs, it's inevitable to run into questions that will lead you down rabbit holes for every row in your list. Instead of spending hours trawling through drug data, clinical trials, and company filings, now you can just add an AI Column.
Think of it as using AI to get answers to a specific question on a list of items. For example, "for each of these 50 breast cancer drugs, find PFS and OS in triple-negative breast cancer."
Once you've built a list, you can add an AI Column:
Enter 1-2 sentences of instructions about what you want the AI Analyst to research, such as:
"For each of these drugs, identify the PFS and OS in triple-negative breast cancer."
"Review each transcript and provide commentary from management or analysts about M&A priorities."
That's it! You'll instantly start to see results in the column, and will receive an email when your research is complete. Check back and find the newly added column of answers at the right-hand side of your table.
With this feature, you can enrich drugs, trials, companies, or documents with AI-driven research, saving hours of manual work.
To deeply understand a space, it's important to grasp the history of the relevant drugs, companies, and especially trials. To this end, we're very excited to introduce event feeds. These exist in two forms:
On any drug, company, or trial page, there's now a 'Go to Event Feed' button. This will bring you directly to a feed of relevant events for these entities.
(Pro tip: If you've got a list of records, you can create a unified event feed for them with a single click.)
For example, let's take Relay Therapeutics. We can now see when the company announces M&A activity, updates critical aspects of its trials, or releases results for drug programs.
To dive deeper, we link to both the relevant sources and the related drugs, trials, and companies.
For trial updates, it's even easier: the version is embedded directly into the card!
No more sifting through hundreds of versions on clinicaltrials.gov; we have over 1 million trial versions in our database.
Speaking of trial histories - they're not just available as part of events for drugs and companies. On any trial you might be curious about, we have the whole history embedded within the application.
On a trial detail page, you can navigate to the 'Timeline' page. While researching, you can stay in the zone—no need to constantly switch between clinicaltrials.gov and your research. On Maven Bio, it's all in one place.
Additionally, you can filter just by keys.
Need to know when outcome measures changed? No need to search on clinicaltrials.gov—just select it from the dropdown, and the relevant versions will appear right in the app.
We're committed to expediting your research, getting to the relevant information as fast as possible.
Maven Bio is out of beta!
November 4, 2024
November 4, 2024
Maven Bio is now officially out of beta! We've been hard at work adding new features, finding new documents, and refining the user experience.
Our goal is to take the pain out of BioPharma market research and competitive intelligence. To that end, we have two focuses: (1) building the best database of BioPharma knowledge, and (2) developing AI-driven features that help you conduct research faster.
Our database is stronger than ever. Since launching our beta, we've expanded our database by 10 million documents, grown our list of tracked drugs to almost 70,000, and characterized 1.4 million events across the industry.
With our ever-growing document database, you'll see higher-quality content throughout the app. Most importantly, our AI Analyst is now better prepared to answer your questions! You can receive instant, AI-generated answers to your research queries with in-line citations. Great use cases include:
You can now generate detailed, consultant-like reports tailored to your specific research needs. Simply fill out a short request form, and our AI will get to work building your report, ready in just a few hours.
We've built five different types of reports, all designed to help you get up to speed on an area of interest:
Creating a report is simple! Right from the homepage, you can get started:
It's easy to select the type of report:
Then fill in what you're looking for:
And that's it! You'll receive an email when your report is ready.